Clinical Trials Browser

Phase 1/2 × Leukemia, Myeloid, Acute × Everolimus × Clear all

NCT00081874 2025-04-27

RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, T-Cell, Leukemia, Myeloid, Acute, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT00762632 2012-08-08

Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia

Phase 1/2 Completed

40 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute